EYD 001
Alternative Names: EYD-001; HS-276Latest Information Update: 16 Jan 2025
Price :
$50 *
At a glance
- Originator EydisBio
- Class Amides; Antirheumatics; Imidazoles; Piperidines; Skin disorder therapies; Small molecules
- Mechanism of Action MAP kinase kinase kinase 7 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Arthritis; Peripheral neuropathies; Rheumatoid arthritis; Systemic scleroderma
- Research Pain; Systemic lupus erythematosus